caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1518924729

Carlos Garcia-RiveraD.O.

PRACTICECARLOS A GARCIA-RIVERA, DOPASee all providers at this practice →
NeurologyMiami, FLI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$5K
Payment records
208
By payment type
Food and Beverage$5K
REFERRAL NETWORK

Where Carlos Garcia-Rivera's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Laboratory Corporation Of America
Clinical Laboratory · Tampa, FL
1419
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
9,613
Beneficiaries
—
Total drug cost
$1.2M
Distinct drugs
69
Brand share
27.0%
Top prescribed drugs
Gabapentin984 claims
Memantine Hcl923 claims
Memantine Hcl693 claims
Carbidopa/Levodopa668 claims
Pregabalin594 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
164
Unique beneficiaries
—
Total services
233
Distinct HCPCS
2
Medicare payment
$25K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,241 Neurology providers in FL — below median (cohort median 598).